Mersana is a biopharmaceutical company specializing in the discovery and development of antibody-drug conjugate (ADC) therapies to treat patients fighting cancer.

Biotechnology

Mersana Therapeutics

Mersana Therapeutics' headquarters in Cambridge, MA, United States

Katharin Blackerby-Burke

Brian C. Deschuytner

Timothy B. Lowinger

Lei Zhu

Caryn Crasnick-Maloney

Richard Fredericks

Brigitte Eichner

Mohan Bala

Michael Kaufman

Ashish Mandelia

Srikanth Chebrolu

Marina Protopopova

Roman S. Erdmann

Robert Burger

Reddy Bollu

Scott David Collins

Nitin Dixit

Natalie Keirstead

Tarek Abdeljawad

Kavita Baba

Adi Reske

Lauren Kimball

Jennie Perkins

Vandana Singhal

Ashley Mullan

Lawrence M. Alleva

K. Dane Wittrup

Andrew Hack

Peter A. Kiener

Christoph Lengauer

Willard H. Dere

Kristen M. Hege

Allene M. Diaz

Howard A. Skip Burris III

The Clinical Development team at Mersana Therapeutics plays a critical role in advancing the company’s antibody-drug conjugate therapies through clinical trials. This multidisciplinary group, comprising experts in clinical operations, research, biostatistics, and quality assurance, collaborates to design, implement, and oversee clinical studies that evaluate the safety and efficacy of new treatments for cancer patients. Their efforts ensure compliance with regulatory standards while facilitating the translation of innovative research into viable therapeutic options.

Clinical Development

The Leadership Team at Mersana Therapeutics drives the strategic vision and operational efficiency of the company, overseeing critical functions such as legal affairs, regulatory compliance, scientific research, development, and manufacturing. Each member brings expertise from their respective fields to ensure the successful advancement of innovative antibody-drug conjugate therapies, ultimately improving patient outcomes in the fight against cancer.

Leadership Team

The Regulatory and Compliance team at Mersana Therapeutics ensures that all clinical and business activities adhere to regulatory standards and industry best practices. This team oversees the preparation and submission of regulatory documents, monitors pharmacovigilance activities, and ensures compliance with SEC reporting requirements, while also providing legal guidance to support the development of ADC therapies for cancer treatment.

Regulatory and Compliance

This department manages financial operations and executive support functions.

Finance and Administration

This department oversees strategic direction and organizational management.

Leadership Operations

This department focuses on scientific research, innovation, and the development of new products and technologies.

Research and Development

Mersana Therapeutics

Org chart

Board & advisors

Teams

Clinical Development

Leadership Team

Regulatory and Compliance

Finance and Administration

Leadership Operations

Research and Development

Offices

Mersana Therapeutics

Org chart

Board & advisors

Teams

Clinical Development

Leadership Team

Regulatory and Compliance

Finance and Administration

Leadership Operations

Research and Development

Offices

Related companies